IMO the takeover price will be quite dependant on the prevailing SP at the time of the offer. I have researched T/O premiums for orphan drug biotechs and it seems anywhere between 30 and 175% is possible with the majority of transactions happening in the 50-100% range (skewed to the mid to upper end). The probability of a 2-3x offer from the current price is exceedingly low.
So atm my view is if a T/O was launched today we are looking at a $21-28 range, more likely $25-28. Jon has already stated he won’t engage with any possible suitor until P2 NNZ2591 are out. The probability is that they will be successful and should the SP be, say, $18 at that time then the possible T/O price becomes a likely range of say $28-36, hopefully skewed to the upper number.
Lower than that I would be a little disappointed. So they key to the possible T/O price will, imo, be the prevailing SP after the P2 results. That is something we are going to have to wait and find out.
- Forums
- ASX - By Stock
- What will Neu with surplus funds ??
IMO the takeover price will be quite dependant on the prevailing...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.80 |
Change
-0.170(0.85%) |
Mkt cap ! $2.552B |
Open | High | Low | Value | Volume |
$19.96 | $19.96 | $19.71 | $262.1K | 13.20K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 148 | $19.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.81 | 46 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 9 | 19.900 |
5 | 61 | 19.890 |
2 | 106 | 19.880 |
7 | 682 | 19.870 |
4 | 219 | 19.860 |
Price($) | Vol. | No. |
---|---|---|
19.910 | 44 | 1 |
19.930 | 292 | 4 |
19.940 | 172 | 3 |
19.950 | 181 | 4 |
19.960 | 163 | 2 |
Last trade - 10.26am 05/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |